[ad_1]
(CBS) – New vaccine may soon allow those who suffer from celiac disease eat gluten safely.
The vaccine, NexVax2, uses the body's own medicines immune system treat celiac disease.
Researchers If the vaccine is administered in small amounts at the beginning and the dosage is gradually increased, people with celiac disease will become resistant to the harmful effects of the harmful protein contained in the gluten.
People with celiac disease should still be on a gluten-free diet.
In 2017, Massachusetts-based ImmusanT received $ 40 million in funding to finance research in NexVax2.
One year later, the first patient in a clinical trial received the vaccine and showed signs of progress.
This first step shows promising signs for the launch of the phase 2 clinical trial, called RESET CeD.
The RESET CeD test is designed to determine the effectiveness of the vaccine and determine if the benefits outweigh the risks.
ImmusanT ultimately seeks to develop a vaccine that would eliminate the need for a gluten-free diet.
The researchers estimate that it will take at least five years before a drug is available to patients, but they claim that research on celiac disease treatments has accelerated.
RELATED: A girl with celiac disease writes a book if the condition is "better understood"
Source link
